MSB 2.51% 97.0¢ mesoblast limited

Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD, page-10

  1. 105 Posts.
    lightbulb Created with Sketch. 14
    Is there any new information here? Looks like recycled data from the trials
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.